01 19NALPROPION
02 1TWI PHARMS
01 17375111
02 17674479
03 18088786
04 18318788
05 18722085
06 18916195
07 19107837
08 19125868
09 19248123
10 19633575
11 110231964
12 110307376
13 110403170
14 110828294
15 110835527
16 111033543
17 111139056
18 111324741
19 111998542
20 112048769
01 20Blank
01 3Y
02 17Blank
01 12025-03-26
02 12027-06-04
03 12027-06-25
04 52027-11-08
05 12029-02-03
06 12029-05-29
07 12030-02-02
08 12031-01-10
09 12032-01-13
10 22033-06-05
11 12033-06-25
12 42034-07-02
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8722085
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2027-06-04
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 9107837
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1639
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-06-04
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 9125868
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2034-07-02
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 10231964
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2034-07-02
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 10307376
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2034-07-02
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 11998542
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2034-07-02
Patent Expiration Date : 2033-06-05
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 11139056
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2033-06-05
Patent Expiration Date : 2033-06-05
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 10403170
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2033-06-05
Patent Expiration Date : 2033-06-25
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 9633575
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2033-06-25
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 12048769
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
